PRESS RELEASE

     

PCAS 8% BONDS DATED- 31/12/2016 BUY BACK

Longjumeau, 15th February 2016,

PCAS announces they have repurchased a total of 7 439 PCAS' 8%  Bonds dated 31/12/2016 (FR 0010480707) out of the 33 333 bonds issued in 2007, representing approximately 22,3% of the outstanding bonds.

This operation, which will achieve savings in financial charges, fits in the PCAS' financial debt optimization strategy.

ABOUT PCAS
PCAS specialises in the development and production of complex molecules for Life Sciences and Innovative Technologies. With 7% of its turnover dedicated to R&D and a wide international presence, PCAS is the preferred industrial partner of market-leading major global groups. The company offers a growing range of proprietary products and solutions in leading-edge segments, and also includes two subsidiaries with very strong potential: Protéus in biotechnology and Enersens in high-performance insulation. With a particularly high standard of performance, PCAS achieved net sales of €179.1 million in 2015 and employs nearly 900 people in six countries.

For more information about PCAS: www.pcas.com

 

 

 

 

 

 

 

PCAS		  

 

 

 

 

 

 

NewCap
Vincent Touraille / Eric Moissenot
PCAS		 Emmanuel Huynh / Louis-Victor Delouvrier
NewCap
Financial Communication & investors relations
Tel. : +33 1 69 79 61 32
www.pcas.com

 		 Tel. : +33 1 44 71 98 53
pcas@newcap.eu
PR_PCAS_bonds buy back


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: PCAS via Globenewswire
HUG#1986260